Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013–2018)

References

• Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, Franco MA, Greenberg HB, O'Ryan M, Kang G, et al. Rotavirus infection. Nat Rev Dis Primers. 2017;3(1):17083. doi:10.1038/nrdp.2017.83.
   PubMed Web of Science ®Google Scholar
• Ardura-García C, Kreis C, Rakic M, Jaboyedoff M, Mallet MC, Low N, Kuehni CE. Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis. Vaccine. 2021;39(22):2917–10. doi:10.1016/j.vaccine.2021.04.039.
   PubMed Web of Science ®Google Scholar
• Álvarez Aldeán J, Aristegui J, López-Belmonte JL, Pedrós M, Sicilia JG. Economic and psychosocial impact of rotavirus infection in Spain: a literature review. Vaccine. 2014;32:3740–51. doi:10.1016/j.vaccine.2014.04.058.
   PubMed Web of Science ®Google Scholar
• Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of Rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006–2016. Clin Infect Dis. 2017;65(5):840–50. doi:10.1093/cid/cix369.
   PubMed Web of Science ®Google Scholar
• Diez-Domingo J, Garces-Sanchez M, Gimenez-Sanchez F, Colomina-Rodriguez J, Martinon-Torres F. What have we learnt about rotavirus in Spain in the last 10 years? An Pediatr (Barc). 2019;91:166–79.
   PubMed Web of Science ®Google Scholar
• Pereira P, Vetter V, Standaert B, Benninghoff B. Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned. Expert Rev Vaccines. 2020;19(8):755–69. doi:10.1080/14760584.2020.1800459.
   PubMed Web of Science ®Google Scholar
• de Hoog MLA, Vesikari T, Giaquinto C, Huppertz HI, Martinon-Torres F, Bruijning-Verhagen P. Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC). Hum Vaccin Immunother. 2018;14(4):1027–34. doi:10.1080/21645515.2017.1412019.
   PubMed Web of Science ®Google Scholar
• Rotateq SMPC. Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/rotateq-epar-product-information_en.pdf
   Google Scholar
• Rotarix SRMPC. Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/rotarix-epar-product-information_en.pdf
   Google Scholar
• Ruiz-Contreras J, Alfayate-Miguelez S, Carazo–gallego B, Onísís E, Díaz-Munilla L, Mendizabal M, Méndez Hernández M, Ferrer-Lorente B, Unsaín-Mancisidor M, Ramos-Amador JT, et al. Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013–2018. BMC Infect Dis. 2021;21(1):1138. doi:10.1186/s12879-021-06841-x.
   PubMed Web of Science ®Google Scholar
• Garcia-Basteiro AL, Bosch A, Sicuri E, Bayas JM, Trilla A, Hayes EB. Hospitalizations due to rotavirus gastroenteritis in Catalonia, Spain, 2003-2008. BMC Res Notes. 2011;4(1):429. doi:10.1186/1756-0500-4-429.
   PubMedGoogle Scholar
• Gil A, Carrasco P, Jimenez R, San-Martin M, Oyaguez I, Gonzalez A. Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999–2000. Vaccine. 2004;22(17–18):2221–25. doi:10.1016/j.vaccine.2003.11.037.
   PubMed Web of Science ®Google Scholar
• Lopez-de-Andres A, Jimenez-Garcia R, Carrasco-Garrido P, Alvaro-Meca A, Galarza PG, de Miguel AG. Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001–2005. BMC Public Health. 2008;8(1):109. doi:10.1186/1471-2458-8-109.
   PubMedGoogle Scholar
• Luquero FJ, Hernan Garcia C, Eiros Bouza JM, Castrodeza Sanz J, Sanchez-Padilla E, Simon Soria F, Ortiz de Lejarazu Leonardo R. Perfil de ingresos y urgencias pediátricas en período epidémico de rotavirus en Valladolid. Utilidad de un modelo predictivo. Gac Sanit. 2009;23(1):58–61. doi:10.1016/j.gaceta.2008.03.004
   PubMedGoogle Scholar
• Resources. Guidelines for good pharmacoepidemiology practices (GPP). 2015. https://www.pharmacoepi.org/resources/policies/guidelines-08027/ .
   Google Scholar
• Ogilvie I, Khoury H, Goetghebeur MM, El Khoury AC, Giaquinto C. Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infect Dis. 2012;12(1):62. doi:10.1186/1471-2334-12-62.
   PubMedGoogle Scholar
• Oblikue. eSalud platform. https://www.oblikue.com/en/esalud.html
   Google Scholar
• Orrico-Sanchez A, Lopez-Lacort M, Perez-Vilar S, Diez-Domingo J. Long-Term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain. BMC Infect Dis. 2017;17(1):267. doi:10.1186/s12879-017-2380-2.
   PubMedGoogle Scholar
• Base de datos de medicamentos y parafarmacia (Botplus). Consejo General de colegios Farmacéuticos. Botplus. https://www.farmaceuticos.com/botplus/
   Google Scholar
• Instituto Nacional de Estadística. Demografía y población. https://www.ine.es/index.htm
   Google Scholar
• Dennehy PH, Cortese MM, Bégué RE, Jaeger JL, Roberts NE, Zhang R, Rhodes P, Gentsch J, Ward R, Bernstein DI, et al. A case-control study to determine risk factors for hospitalization for Rotavirus Gastroenteritis in U.S. children. Pediatr Infect Dis J. 2006;25(12):1123–31. doi:10.1097/01.inf.0000243777.01375.5b.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Van Damme P, Giaquinto C, Dagan R, Guarino A, Szajewska H, Usonis V. European society for paediatric infectious diseases consensus recommendations for rotavirus vaccination in Europe: update 2014. Pediatr Infect Dis J. 2015;34(6):635–43. doi:10.1097/INF.0000000000000683.
   PubMed Web of Science ®Google Scholar
• Aristegui J, Ferrer J, Salamanca I, Garrote E, Partidas A, San-Martin M, San-Jose B. Multicenter prospective study on the burden of rotavirus gastroenteritis in children less than 3 years of age in Spain. BMC Infect Dis. 2016;16(1):549. doi:10.1186/s12879-016-1890-7.
   PubMedGoogle Scholar
• Gimenez-Sanchez F, Delgado-Rubio A, Martinon-Torres F, Bernaola-Iturbe E; Rotascore Research Group. Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain. Acta Paediatr. 2010;99(5):738–42. doi:10.1111/j.1651-2227.2010.01684.x.
   PubMed Web of Science ®Google Scholar
• GarcíGarcíA-Magán C, de Castro-López MJ, Llovo-Taboada J, Curros-Novo C, Puente-Puig M, Sánchez-Fauquier A, Martinón-Torres F. Caracterización microbiológica de las gastroenteritis agudas virales atendidas en un servicio de pediatría en un área de alta cobertura vacunal frente a rotavirus. Enfermedades Infecciosas Y microbiología Clínica. 2014;32(4):246–49. doi:10.1016/j.eimc.2013.09.008.
   PubMedGoogle Scholar
• Kang B, Kim DH, Hong YJ, Son BK, Kim DW, Kwon YS. Comparison between febrile and afebrile seizures associated with mild rotavirus gastroenteritis. Seizure. 2013;22:560–64. doi:10.1016/j.seizure.2013.04.007.
   PubMed Web of Science ®Google Scholar
• Le Saux N, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW. Canadian Immunization Monitoring Program, Active (IMPACT). Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals. Pediatr Infect Dis J. 2010;29(9):879–82. doi:10.1097/INF.0b013e3181e20c94.
   PubMed Web of Science ®Google Scholar
• Lloyd MB, Lloyd JC, Gesteland PH, Bale JJ. Rotavirus gastroenteritis and seizures in young children. Pediatr Neurol. 2010;42(6):404–08. doi:10.1016/j.pediatrneurol.2010.03.002.
   PubMed Web of Science ®Google Scholar
• Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, Curns AT, Weintraub E, Parashar UD. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis. 2014;58(2):173–77. doi:10.1093/cid/cit671.
   PubMed Web of Science ®Google Scholar
• Gavilán Martín C, García Avilés B, González Montro R. Gastroenteritis aguda. Protocolos diagnóstico-terapéuticos de infectología. Madrid: Ergon; 2011pp. 113–24.
   Google Scholar
• Costa I Pagés J, Polanco Allué I, Rodrigo Gonzalo de Liria C. Guía Práctica Clínica. Gastroenteritis guda en el el niño. SEGHNP-SEIP 2010. https://portal.guiasalud.es/wp-content/uploads/2018/12/GPC_464_Gastroenteritis.pdf
   Google Scholar
• De la Torre A. Gastroenteritis Aguda (V.4.0/2019). Guia ABE-. Infecciones en pediatría. guía rápida para la selección del tratamiento antomicrobiano empírico. Available at: https://www.guia-abe.es/temas-clinicos-gastroenteritis-aguda
   Google Scholar
• van den Berg J, Berger MY. Guidelines on acute gastroenteritis in children: a critical appraisal of their quality and applicability in primary care. BMC Fam Pract. 2011;12(1):134. doi:10.1186/1471-2296-12-134.
   PubMedGoogle Scholar
• de la Flor J. Gastroenteritis aguda. Pediatr Integral. 2019;23:348–55.
   Google Scholar
• Giaquinto C, van Damme P, Huet F, Gothefors L, van der Wielen M; . REVEAL Study Group; Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL study. J Infect Dis. 2007;195 Suppl 1(s1):S36–44. doi:10.1086/516716.
   PubMedGoogle Scholar
• Hagedoorn NN, Borensztajn DM, Nijman R, Balode A, von Both U, Carrol EN, Eleftheriou I, Emonts M, van der Flier M, de Groot R, et al. Variation in antibiotic prescription rates in febrile children presenting to emergency departments across Europe (MOFICHE): A multicentre observational study. PLoS Med. 2020;17(8):e1003205. doi:10.1371/journal.pmed.1003208.
   Web of Science ®Google Scholar
• Vekemans J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, Fiore A, Tayler E, Klemm EJ, Laxminarayan R, Srikantiah P, Friede M, et al. Leveraging vaccines to reduce antibiotic use and prevent antomicrobial resistance: a World Health Organization action framework. Clin Infect Dis. 2021;73(4):e1011–7. doi:10.1093/cid/ciab062.
   PubMed Web of Science ®Google Scholar
• Malarski M, Hasso-Agopsowicz M, Soble A, Mok W, Mathewson S, Vekemans J. Vaccine impact on antimicrobial resistance to inform GAVI, the Vaccine Alliance’s 2018 vaccine investment strategy: report from an expert survey. F1000 Research. 2019;8:1685. doi:10.12688/f1000research.20100.1.
   PubMedGoogle Scholar
• Gil-Prieto R, San Martín M, de Andrés AL, Alvaro-Meca A, González A, de Miguel AG. Hospital-Acquired rotavirus infections in Spain over a ten-year period (1998-2007). Hum Vaccin. 2009;5(11):748–53. doi:10.4161/hv.5.11.9792.
   PubMed Web of Science ®Google Scholar
• Tran AN, Husberg M, Bennet R, Brytting M, Carlsson P, Eriksson M, Storsaeter J, Österlin B, Johansen K. Impact on affected families and society of severe rotavirus infections in Swedish children assessed in a prospective cohort study. Infect Dis (Lond). 2018;50(5):361–71. doi:10.1080/23744235.2017.1416162.
   PubMed Web of Science ®Google Scholar
• Bouzón-Alejandro M, Redondo-Collazo L, Sánchez-Lastres JM, Martinón-Torres N, Martinón-Sánchez JM, Martinón-Torres F, et al. Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: the ROTACOST study. BMC Pediatr. 2011;11:81. doi:10.1186/1471-2431-11-81.
   PubMed Web of Science ®Google Scholar
• Bruijning-Verhagen P, Nipshagen MD, de Graaf H, Bonten MJM. Rotavirus disease course among immunocompromised patients: 5-year observations from a tertiary care medical centre. J Infect. 2017;75(5):448–54. doi:10.1016/j.jinf.2017.08.006.
   PubMed Web of Science ®Google Scholar